Nitrate enhances skeletal muscle fatty acid oxidation via a nitric oxide-cGMP-PPAR-mediated mechanism

被引:39
|
作者
Ashmore, Tom [1 ,2 ]
Roberts, Lee D. [2 ,3 ]
Morash, Andrea J. [1 ]
Kotwica, Aleksandra O. [1 ]
Finnerty, John [1 ]
West, James A. [2 ]
Murfitt, Steven A. [2 ]
Fernandez, Bernadette O. [4 ]
Branco, Cristina [1 ]
Cowburn, Andrew S. [1 ]
Clarke, Kieran [5 ]
Johnson, Randall S. [1 ]
Feelisch, Martin [4 ]
Griffin, Julian L. [2 ,3 ]
Murray, Andrew J. [1 ]
机构
[1] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3EG, England
[2] Univ Cambridge, Dept Biochem, Cambridge CB2 3EG, England
[3] Univ Cambridge, MRC Human Nutr Res, Cambridge CB2 3EG, England
[4] Univ Southampton, Fac Med Clin & Expt Sci, Southampton, Hants, England
[5] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England
来源
BMC BIOLOGY | 2015年 / 13卷
基金
英国医学研究理事会; 加拿大自然科学与工程研究理事会; 英国生物技术与生命科学研究理事会;
关键词
Fatty acid oxidation; Metabolism; Mitochondria; Muscle; Nitrate; Nitric oxide; WHITE ADIPOSE-TISSUE; HIGH-ALTITUDE HYPOXIA; DIETARY NITRATE; INSULIN-RESISTANCE; CPT-I; METABOLIC ADAPTATION; MALONYL-COA; RAT-HEART; HUMANS; MITOCHONDRIA;
D O I
10.1186/s12915-015-0221-6
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: Insulin sensitivity in skeletal muscle is associated with metabolic flexibility, including a high capacity to increase fatty acid (FA) oxidation in response to increased lipid supply. Lipid overload, however, can result in incomplete FA oxidation and accumulation of potentially harmful intermediates where mitochondrial tricarboxylic acid cycle capacity cannot keep pace with rates of beta-oxidation. Enhancement of muscle FA oxidation in combination with mitochondrial biogenesis is therefore emerging as a strategy to treat metabolic disease. Dietary inorganic nitrate was recently shown to reverse aspects of the metabolic syndrome in rodents by as yet incompletely defined mechanisms. Results: Herein, we report that nitrate enhances skeletal muscle FA oxidation in rodents in a dose-dependent manner. We show that nitrate induces FA oxidation through a soluble guanylate cyclase (sGC)/cGMP-mediated PPAR beta/delta- and PPAR alpha-dependent mechanism. Enhanced PPAR beta/delta and PPAR alpha expression and DNA binding induces expression of FA oxidation enzymes, increasing muscle carnitine and lowering tissue malonyl-CoA concentrations, thereby supporting intra-mitochondrial pathways of FA oxidation and enhancing mitochondrial respiration. At higher doses, nitrate induces mitochondrial biogenesis, further increasing FA oxidation and lowering long-chain FA concentrations. Meanwhile, nitrate did not affect mitochondrial FA oxidation in PPAR alpha(-/-) mice. In C2C12 myotubes, nitrate increased expression of the PPARa targets Cpt1b, Acadl, Hadh and Ucp3, and enhanced oxidative phosphorylation rates with palmitoyl-carnitine; however, these changes in gene expression and respiration were prevented by inhibition of either sGC or protein kinase G. Elevation of cGMP, via the inhibition of phosphodiesterase 5 by sildenafil, also increased expression of Cpt1b, Acadl and Ucp3, as well as CPT1B protein levels, and further enhanced the effect of nitrate supplementation. Conclusions: Nitrate may therefore be effective in the treatment of metabolic disease by inducing FA oxidation in muscle.
引用
收藏
页数:17
相关论文
共 50 条
  • [1] Nitrate enhances skeletal muscle fatty acid oxidation via a nitric oxide-cGMP-PPAR-mediated mechanism
    Tom Ashmore
    Lee D. Roberts
    Andrea J. Morash
    Aleksandra O. Kotwica
    John Finnerty
    James A. West
    Steven A. Murfitt
    Bernadette O. Fernandez
    Cristina Branco
    Andrew S. Cowburn
    Kieran Clarke
    Randall S. Johnson
    Martin Feelisch
    Julian L. Griffin
    Andrew J. Murray
    BMC Biology, 13
  • [2] PPARδ activation enhances fatty acid oxidation in skeletal muscle and attenuates metabolic syndrome
    Sakai, Juro
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2005, 125 : 47 - 48
  • [3] Fuel oxidation in skeletal muscle is increased by nitric oxide cGMP - evidence for involvement of cGMP-dependent protein kinase
    Young, ME
    Leighton, B
    FEBS LETTERS, 1998, 424 (1-2): : 79 - 83
  • [4] A potent PPARα agonist stimulates mitochondrial fatty acid β-oxidation in liver and skeletal muscle
    Minnich, A
    Tian, N
    Byan, L
    Bilder, G
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2001, 280 (02): : E270 - E279
  • [5] Skeletal muscle contractions stimulate cGMP formation and attenuate vascular smooth muscle myosin phosphorylation via nitric oxide
    Lau, KS
    Grange, RW
    Chang, WJ
    Kamm, KE
    Sarelius, I
    Stull, JT
    FEBS LETTERS, 1998, 431 (01) : 71 - 74
  • [6] The Effects of Palmitic Acid on Nitric Oxide Production by Rat Skeletal Muscle: Mechanism via Superoxide and iNOS Activation
    Lambertucci, Rafael Herling
    Leandro, Carol Gals
    Vinolo, Marco Aurelio
    Nachbar, Renato Tadeu
    Silveira, Leonardo dos Reis
    Hirabar, Sandro Massao
    Curi, Rui
    Pithon-Curi, Tania Cristina
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2012, 30 (05) : 1169 - 1180
  • [7] AMPK activation increases fatty acid oxidation in skeletal muscle by activating PPARα and PGC-1
    Lee, WJ
    Kim, M
    Park, HS
    Kim, HS
    Jeon, MJ
    Oh, KS
    Koh, EH
    Won, JC
    Kim, MS
    Oh, GT
    Yoon, M
    Lee, KU
    Park, JY
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 340 (01) : 291 - 295
  • [8] An Ethanol Extract of Artemisia iwayomogi Activates PPARδ Leading to Activation of Fatty Acid Oxidation in Skeletal Muscle
    Cho, Si Young
    Jeong, Hyun Woo
    Sohn, Jong Hee
    Seo, Dae-Bang
    Kim, Wan Gi
    Lee, Sang-Jun
    PLOS ONE, 2012, 7 (03):
  • [9] Increased glucose utilisation in skeletal muscle via a mechanism involving nitric oxide and cyclicGMP
    Leighton, B
    Young, ME
    Jensen, J
    Radda, GK
    DIABETOLOGIA, 1996, 39 : 634 - 634
  • [10] Stimulation of cardiac fatty acid oxidation by leptin is mediated by a nitric oxide-p38 MAPK-dependent mechanism
    Sharma, Vijay
    Mustafa, Sally
    Patel, Natasha
    Wambolt, Richard
    Allard, Michael F.
    McNeill, John H.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2009, 617 (1-3) : 113 - 117